User: Guest  Login
Title:

MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma.

Document type:
Journal Article; Research Support, Non-U.S. Gov't; Article
Author(s):
Elsner, M; Rauser, S; Maier, S; Schone, C; Balluff, B; Meding, S; Jung, G; Nipp, M; Sarioglu, H; Maccarrone, G; Aichler, M; Feuchtinger, A; Langer, R; Jütting, U; Feith, M; Küster, B; Ueffing, M; Zitzelsberger, H; Höfler, H; Walch, A
Abstract:
To characterize proteomic changes found in Barrett's adenocarcinoma and its premalignant stages, the proteomic profiles of histologically defined precursor and invasive carcinoma lesions were analyzed by MALDI imaging MS. For a primary proteomic screening, a discovery cohort of 38 fresh frozen Barrett's adenocarcinoma patient tissue samples was used. The goal was to find proteins that might be used as markers for monitoring cancer development as well as for predicting regional lymph node metasta...     »
Journal title abbreviation:
J Proteomics
Year:
2012
Journal volume:
75
Journal issue:
15
Pages contribution:
4693-704
Language:
eng
Fulltext / DOI:
doi:10.1016/j.jprot.2012.02.012
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/22365974
Print-ISSN:
1874-3919
TUM Institution:
Chirurgische Klinik und Poliklinik; Institut für Allgemeine Pathologie und Pathologische Anatomie
 BibTeX